Guilbault Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$651K Sell
2,459
-75
-3% -$19.8K 0.64% 42
2026
Q2
$644K Hold
2,534
– – 0.65% 34
2026
Q1
$619K Sell
2,534
-40
-2% -$9.32K 0.68% 35
2025
Q4
$533K Buy
+2,574
New +$509K 0.6% 39

Other funds holding JNJ

Guilbault Capital's JNJ Position: Q3 2026 in Review

Guilbault Capital reduced its Johnson & Johnson (JNJ) stake by 3% in Q3 2026, selling an estimated $19.8K and leaving 2,459 shares worth $651K. The position accounts for 0.64% of the portfolio, ranked #42.

Guilbault Capital first reported a position in JNJ in Q4 2025 and has held it in 4 quarters since. 4,734 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Guilbault Capital held 2,459 shares of Johnson & Johnson worth $651K as of Q3 2026.
  • Guilbault Capital sold 75 Johnson & Johnson shares in Q3 2026, an estimated $19.8K.
  • Johnson & Johnson made up 0.64% of Guilbault Capital's portfolio in Q3 2026, its #42 holding.
  • Guilbault Capital first reported a position in Johnson & Johnson in Q4 2025 and has held it in 4 quarters since.
  • 4,734 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Guilbault Capital's 13F filing for Q3 2026, filed 28 Oct 2026.